We are live on ! Find out more
KALA icon

KALA BIO

17 hedge funds and large institutions have $23.7M invested in KALA BIO in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

413% more capital inflows, than outflows

Capital inflows: $6.54M | Capital outflows: $1.27M

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

7.05% less ownership

Funds ownership: 75.06% → 68% (-7.1%)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KALA Hedge Fund Activity: Q1 2025 in Review

17 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2025, worth a combined $23.7M — down 1.2% from $24M a quarter earlier.

Fund positioning in KALA was balanced in Q1 2025: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.1M. The largest seller was Millennium Management, exiting entirely with an estimated $944K sold.

  • 17 institutional investors held KALA BIO (KALA) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $23.7M of KALA BIO stock for Q1 2025, down 1.2% quarter-over-quarter.
  • 4 funds opened new KALA BIO positions in Q1 2025 and 4 closed out, a net change of 0 holders.
  • The largest KALA BIO buyer in Q1 2025 was Perceptive Advisors, an estimated $2.1M added.
  • The largest KALA BIO seller in Q1 2025 was Millennium Management, an estimated $944K sold.

Based on aggregated 13F filings for Q1 2025.